The wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14- year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

Ophthalmology

Volumn 105, Issue 10, 1998, Pages 1801-1815

  Klein, Ronald ^a,b   Klein, Barbara E K ^a   Moss, Scot E ^a   Cruickshanks, Karen J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; COMORBIDITY; DIABETIC RETINOPATHY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; VISUAL ACUITY;

EID: 0031793875     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)91020-X     Document Type: Article

References (78)

1. Klein R, Klein BEK. Vision disorders in diabetes. In: Diabetes in America. National Diabetes Data Group. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1995;293-338. (NIH publication; no. 95-1468).
2. Tielsch JM. Vision Problems in the U.S. Schaumburg, IL: Prevent Blindness America, 1994;1-20.
3. Moss SE, Klein R, Klein BEK. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994;101:1061-70.
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329: 977-86.
5. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981; 88:583-600.
6. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-806.
7. Dorf A, Ballintine EJ, Bennett PH, Miller M. Retinopathy in Pima Indians. Relationships to glucose level, duration of diabetes, age at diagnosis of diabetes, and age at examination in a population with a high prevalence of diabetes mellitus. Diabetes 1976;25:554-60.
8. Bennett PH, Rushforth NB, Miller M, LeCompte PM. Epidemiologic studies of diabetes in the Pima Indians. Recent Prog Horm Res 1976;32:333-76.
9. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
10. West KM, Erdreich LJ, Strober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 1980;29:501-8.
11. King H, Balkau B, Zimmet P, et al. Diabetic retinopathy in Nauruans. Am J Epidemiol 1983;117:659-67.
12. Ballard DJ, Melton LJ III, Dwyer MS, et al. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 1986;9:334-42.
13. Danielsen R, Jonasson F, Helgason T. Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland. Acta Med Scand 1982;212:277-80.
14. Constable IJ, Knuiman MW, Welborn TA, et al. Assessing the risk of diabetic retinopathy. Am J Ophthalmol 1984;97:53-61.
15. Knuiman MW, Welborn TA, McCann VJ, et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-9.
16. Sjolie AK. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 1985;172:1-77.
17. Nielsen NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol (Copenh) 1984;62:256-65.
18. Teuscher A, Schnell H, Wilson PW. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 1988;11:246-51.
19. Haffner SM, Fong D, Stern MP, et al. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes 1988; 37:878-84.
20. Jerneld B. Prevalence of diabetic retinopathy. A population study from the Swedish island of Gotland. Acta Ophthalmol Suppl 1988;188:3-32.
21. Hamman RF, Mayer EJ, Moo-Young GA, et al. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989;38:1231-7.
22. McLeod BK, Thompson JR, Rosenthal AR. The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town. Eye 1988;2:424-30.
23. Kostraba JN, Klein R, Dorman JS, et al. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991; 133:381-91.
24. Lloyd CE, Klein R, Maser RE, et al. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications 1995;9:140-8.
25. Fukuda M. Natural history of diabetic retinopathy and its treatment in Japan. In: Baba S, Goto Y, Fukui I, eds. Diabetes Mellitus in Asia: ecological aspects of epidemiology, complications and treatment: proceedings of the second symposium, Kyoto, Japan. Amsterdam: Excerpta Medica; New York: Sole dist. for the U.S.A. and Canada Elsevier North Holland, 1976; 225-31 (Int'l Congress series; no. 390).
26. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
27. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
28. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Reginopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107: 237-43.
29. Sjolie AK, Stephenson J, Aldington S, et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 1997; 104:252-60.
30. Klein R, Palta M, Allen C, et al. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol 1997;115:351-6.
31. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168-88, 252-63.
32. Krolewski AS, Warram JH, Rand LI, et al. Risk of proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a 40-year follow-up study. Diabetes Care 1986;9:443-52.
33. Yanko L, Golbourt U, Michaelson IC, et al. Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol 1983;67:759-65.
34. Lee ET, Lee VS, Lu M, Russell D. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes 1992;41:359-67.
35. Lee ET, Lee VS, Kingsley RM, et al. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care 1992;15:1620-7.
36. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
37. Klein R, Klein BEK, Moss SE, et al. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 1984;119: 54-61.
38. The hypertension detection and follow-up program. Hypertension Detection and Follow-Up Program Cooperative Group. Prev Med 1976;5:207-15.
39. Early Treatment Diabetic Retinopathy Study (ETDRS). Manual of Operations. 1985; Chapters 12, 18. Available from: National Technical Information Service (Accession #PB85223006).
40. Quick-Step, Fast Hemoglobin Test System. Akron, OH: Isolab, 1981;1-8.
41. Moss SE, Klein R, Klein BEK, et al. Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 1988;41:645-9.
42. DCCT Research Group, Klein R, Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1995;155:745-54.
43. Klein R, Klein BEK, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology 1986; 93:1183-7.
44. Grading diabetic retinopathy from stereoscopic color fundus photographs -an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):786-806.
45. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:823-33.
46. Klein BEK, Davis MD, Segal P, et al. Diabetic retinopathy. Assessment of severity and progression. Ophthalmology 1984;91:10-7.
47. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
48. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
49. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989;238-45 (Wiley series in probability and mathematical statistics).
50. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. New York: Chichester; J. Wiley, 1995;160-77.
51. LaPorte RE, Matsushima M, Chang Y-F. Prevalence and incidence of insulin-dependent diabetes. In: Diabetes in America. National Diabetes Data Group. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995;37-46 (NIH publication; no. 95-1468).
52. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care 1996;19:744-50.
53. Klein R, Klein BEK, Moss SE, et al. Glycosylated homoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988;260:2864-71.
54. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
55. Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 1984;91:1464-74.
56. Klein R, Moss SE, Klein BEK, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501-10.
57. Vitale S, Maguire MG, Murphy RP, et al. Clinically significant macular edema in Type I diabetes. Incidence and risk factors. Ophthalmology 1995;102:1170-6.
58. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9.
59. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus [letter]. N Engl J Med 1995;332:1305-6.
60. Danne T, Weber B, Hartmann R, et al. Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 1994; 17:1390-6.
61. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
62. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch Ophthalmol 1995;113:36-51.
63. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 1995;102:647-6.
64. Klein BEK, Klein R, Moss SE, Palta M. A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol 1995;113:601-6.
65. Klein R, Klein BEK, Moss SE, et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989;149:2427-32.
66. Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998;351:28-31.
67. Klein R, Moss SE, Klein BEK. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 1993;100:1140-6.
68. Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy. J Diabet Complications 1987;1:96-9.
69. Aiello LM, Rand LI, Briones JC, et al. Monocular clinical risk factors in the progression of diabetic retinopathy. In: Little HL, Jack RL, Patz A, Forsham PH, eds. Diabetic Retinopathy. New York: Thieme-Stratton; Stuttgart; New York: G. Thieme Verlas, 1983.
70. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987;294:1651-4.
71. Winocour PH, Durrington PN, Ishola M, et al. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987;294:1648-51.
72. Moss SE, Klein R, Klein BEK. Association of cigarette smoking with diabetic retinopathy. Diabetes Care 1991;14:119-26.
73. Moss SE, Klein R, Klein BEK. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 1996;103:1438-42.
74. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):757-65.
75. Murphy RP, Nanda M, Plotnick L, et al. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol 1990;108: 215-8.
76. Kostraba JN, Dorman JS, Orchard TJ, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989; 12:686-93.
77. Screening guidelines for diabetic retinopathy. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Ann Intern Med 1992; 116:683-5.
78. Klein R, Moss SE, Klein BEK, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989;149:266-72.